Delivery Order SPE2DB22D3501-SPE2DB25FTL46

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $1,397.77 Delivery Order is for the supply of Amoxicillin-Clavulanate 875-125 mg tablets, which are a commonly prescribed antibiotic medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical division, valued up...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,661.60 firm-fixed-price delivery order is for the supply of Amoxicillin-Clavulanate 500-125 mg tablets to support military healthcare programs. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Amoxicillin-Clavulanate 875-125 mg tablets. The award, valued at $9,270.65, is a firm fixed-price delivery order contract with an ultimate completion date of October 16, 2024. The contract does not have a set-aside designation. As one of Amerisourcebergen's numerous federal contract vehicles, this award is likely part of the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,604,024 units of Amoxicillin-Clavulanate 875-125 mg tablets in 100-count packages. The contract has a ceiling value of $3,490.34 and a completion date of May 15, 2024. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,826.37 firm fixed-price delivery order is for the supply of 100 tablets of Amoxicillin-Clavulanate 875-125 mg, a common antibiotic medication. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,251.86 award is for the delivery of Amoxicillin-Clavulanate 250-125 mg tablets, a prescription pharmaceutical product, to support military treatment programs. Amerisourcebergen Drug Corp is the prime contractor on this order, which does not have a set-aside designation. The award is part of a larger...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of Amoxicillin-Clavulanate 1,000-62.5 mg tablets, a prescription antibiotic medication, with a potential value of $5,406.56 and a performance period through February 2, 2024. Amerisourcebergen Drug Corp holds a larger...
This federal contract award, valued at $385,560.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of various medical supplies, including Amoxicillin-Clavulanate (Amox TR-K CLV 250-62.5/5) tablets, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery...
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FP5S1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,440.68 firm fixed-price delivery order is for the supply of 100 tablets of the drug Amoxicillin-Clavulanate 875-125 mg. This order falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,250.20 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,564,085,230 units of the drug Amoxicillin-Clavulanate 500-125 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which provides a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTL46
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,054.12 firm fixed-price delivery order is for the supply of Amoxicillin-Clavulanate 500-125 mg tablets, a common antibiotic medication, with a completion date of November 13, 2024.

The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/11/25, 10:05 AM